Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GLYATL1P2 is a human pseudogene, meaning it is a segment of DNA that resembles a gene but does not encode a functional protein. It has been assigned the approved gene symbol GLYATL1P2 by the Human Gene Nomenclature Committee (HGNC:37863, NCBI Gene:100129933, Ensembl:ENSG00000254717)[2]. Pseudogenes such as GLYATL1P2 do not produce active protein products and are not recognized as therapeutic targets (such as receptors, enzymes, or transporters). As such, they do not have known biological functions, are not associated with disease roles, do not interact with drugs, and are not used as biomarkers or have known safety concerns[2]. No evidence in the reviewed sources suggests GLYATL1P2 is involved in any molecular pathway, clinical disorder, or pharmacological intervention. If the intent was to refer to an active target related to glycine N-acyltransferase, the correct gene is likely GLYATL1 (Glycine-N-acyltransferase like 1), not GLYATL1P2. GLYATL1P2 is not a functional protein-coding gene and not a therapeutic target; its main designation is as a pseudogene[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine-N-acyltransferase like 1 pseudogene 2 (GLYATL1P2).